SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD DEC 05
MCX SILVER DEC 05
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD DEC 05
MCX SILVER DEC 05
MCX CRUDEOIL NOV 16
MCX NATURALGAS OCT 26
USD/INR
EUR/INR
GBP/INR
JPY/INR

10 things you need to know before the opening bell

Asian stocks edge higher, Aussie in demand on recovery signs

Today's stock tips by Sudarshan Sukhani, Mitessh Thakkar

Rupee slumps 27 paise to 72.99 against US dollar in early trade

Ministry of AYUSH asks Patanjali for composition, research data on 'COVID-19 cure' Coronil, not to publicise claims

Updated : June 24, 2020 07:01 AM IST

The Ministry of AYUSH has asked the company to furnish details of the drug’s composition and the research the company has conducted prior to its launch.

Launching its product earlier Tuesday, Patanjali claimed that the medicine can cure COVID-19 within 14 days.

A majority of coronavirus patients recover without medication within 14 days. Drugs and other intrusive medication is administered in extreme cases.

After Baba Ramdev’s Patanjali Ayurved launched its Ayurvedic medicine, Coronil, claiming that it will help in the treatment of coronavirus infection, the Ministry of AYUSH on Tuesday asked the company to furnish details of the drug’s composition and the research the company has conducted prior to its launch.

“Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined,” the Ministry of AYUSH said in a press release.

The ministry has also asked the Uttarakhand government to provide copies of license and approval details granted for the manufacture of Coronil. Patanjali is headquartered in Haridwar, which comes under Uttarakhand’s jurisdiction.

“Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19,” the statement added.

Launching its product earlier Tuesday, Patanjali claimed that the medicine can cure COVID-19 within 14 days. “Facts of the claim and details of the stated scientific study are not known to the Ministry,” the Ministry of AYUSH statement added.

A majority of coronavirus patients recover without medication within 14 days. Drugs and other intrusive medication is administered in extreme cases.

More than 425,000 people have been infected with coronavirus in India and upwards of 14,000 casualties have been recorded in the country. Globally, the infection tally has crossed the nine million mark while the death toll has climbed upwards of 470,000.

No drug or vaccine for the deadly virus has been discovered so far, albeit Gilead Sciences’ medicine, remdesivir, has been found to reduce the amount of time COVID-19 patients spend in hospital.

You May Also Like

Wipro's BFSI business to grow with $1.45 billion acquisition of Capco

Wipro's BFSI business to grow with $1.45 billion acquisition of Capco

Wipro to buy UK-based consultancy Capco for $1.45 bn, its biggest acquisition so far

Wipro to buy UK-based consultancy Capco for $1.45 bn, its biggest acquisition so far

Seeing a commodity boom; gold prices to settle at $1,700-1800/oz in 2021: Citi's Edward Morse

Seeing a commodity boom; gold prices to settle at $1,700-1800/oz in 2021: Citi's Edward Morse

Trending on CNBC-TV18

Live TV

recommended for you